PRESS RELEASE
| Issue | Title | |
| Vol 8, No 2 (2021) | Work has begun on the creation of unified clinical guidelines for the treatment of infantile (infant) hemangiomas in children in Russia | Abstract PDF (Rus) |
| article Editorial | ||
| Vol 8, No 2 (2021) | Brief information on infantile hemangiomas | Abstract PDF (Rus) |
| article Editorial | ||
| Vol 5, No 4 (2018) | Gemlibra is registered in Russia – the world’s first drug for the treatment of hemophilia A with subcutaneous administration | Abstract PDF (Rus) |
| Article Editorial | ||
| Vol 4, No 2 (2017) | Revolade drug company Novartis is approved in Russia for use in children over 6 years with a diagnosis of idiopathic thrombocytopenic purpura | Abstract PDF (Rus) |
| Article Editorial | ||
| 1 - 4 of 4 Items | ||
